Candesant Biomedical
PrivateLast Round
Debt
Mar 4, 2025
Total Funding Raised
$54.13M
Company Overview
Candesant Biomedical is a medical device company that develops non-invasive treatments for hyperhidrosis using its proprietary targeted alkali thermolysis technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Candesant Biomedical Comparables
Compare Candesant Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| miraDry, Inc. | 88% | |
| Dermadry Laboratories Inc. | 75% | |
| Botanix Pharmaceuticals Ltd | 67% |
For institutional investors. Book with your work email.
Candesant Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 4, 2025 | ||||
| Series B | Jun 6, 2023 | ||||
| Accelerator | Jun 22, 2020 | ||||
| Series A | Feb 14, 2020 |
For institutional investors. Book with your work email.
Candesant Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KCK MedTech | Series B |
| MedTech Innovator | Accelerator |
| Horizon Technology Finance Corporation | Debt |
| Polaris Partners | Series B, Series A |
| Correlation Ventures | Series B |
| Astia | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2025
$10M debt round led by Horizon Technology Finance Corporation.
- Jun 6, 2023
$35M round led by KCK MedTech.
For institutional investors. Book with your work email.
Candesant Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Candesant Biomedical's valuation, stock price, and market status.
Is Candesant Biomedical a public or private company?
Candesant Biomedical is a private company.
What is the current stock price of Candesant Biomedical?
Candesant Biomedical is a private company, so its shares have no public market price. Caplight tracks Candesant Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Candesant Biomedical worth (valuation)?
Valuation information for Candesant Biomedical is not publicly available.
Can I buy Candesant Biomedical stock?
Candesant Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Candesant Biomedical's last funding round?
Candesant Biomedical's most recent funding round was Debt on March 4, 2025.
Who are the main investors in Candesant Biomedical?
Key investors in Candesant Biomedical include KCK MedTech, MedTech Innovator, Horizon Technology Finance Corporation, Polaris Partners.
Will Candesant Biomedical IPO soon?
No public IPO plans have been announced for Candesant Biomedical.
How can I track Candesant Biomedical secondary market activity?
Caplight tracks bids, offers, and trades in Candesant Biomedical's shares on secondary markets.